NCT07153263 Local Anaesthetic Spread and Sensory Block Range of the Retro-superior Costotransverse Ligament Space Block
| NCT ID | NCT07153263 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Condition | Pulmonary Nodules |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-12 |
| Primary Completion | 2026-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-09-12 with a primary completion date of 2026-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical trial is to investigate the effects of local anesthetic diffusion range and sensory block range during retro-SCTLB(retro superior costotransverse ligament space block) and TPVB(thoracic paravertebral block) in patients undergoing CT-guided lung nodule localization. The main issue of the study is to determine the differences in the diffusion range and sensory block range of local anesthetics between the retro-SCTLB and TPVB nerve block methods.
Eligibility Criteria
Inclusion Criteria: Patients scheduled for CT-guided lung nodule localization under local anesthesia will be selected 1. aged 18-80 years 2. BMI 18-30 kg/m² 3. ASA classification I-III Exclusion Criteria: 1. Allergy to the study drug or local anesthetic; 2. History of opioid abuse; 3. Pre-existing skin infection at the puncture site of ITPN or TPVB; 4. Peripheral infectious neuropathy; 5. Dysfunction of blood coagulation
Contact & Investigator
Tao Shan
STUDY CHAIR
Nanjing First Hospital, Nanjing Medical University
Frequently Asked Questions
Who can join the NCT07153263 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Pulmonary Nodules. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07153263 currently recruiting?
Yes, NCT07153263 is actively recruiting participants. Contact the research team at shantao2021@163.com for enrollment information.
Where is the NCT07153263 trial being conducted?
This trial is being conducted at Nanjing, China, Nanjing, China.
Who is sponsoring the NCT07153263 clinical trial?
NCT07153263 is sponsored by Nanjing First Hospital, Nanjing Medical University. The principal investigator is Tao Shan at Nanjing First Hospital, Nanjing Medical University. The trial plans to enroll 50 participants.